Uncategorized

EpiEndo Pharmaceuticals to Speak at ACCESS CHINA Partnering Forum

September 10th, 2024 (Shanghai) — We are glad to announce that Maria Bech, the Chief Executive Officer of EpiEndo Pharmaceuticals, will be presenting at the ACCESS CHINA Partnering Forum – Autumn Virtual Showcase during September 24th to 25th, and 27th, 2024. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.

About EpiEndo Pharmaceuticals

EpiEndo is a clinical-stage biopharmaceutical company developing an oral drug for chronic obstructive pulmonary diseases (COPD), focusing on enhancing the epithelial immune response to reduce the frequency, duration and severity of exacerbations.

About the speaker

Maria Bech has 30 years’ experience working across the pharmaceutical industry. With valuable expertise in drug development strategies, clinical programs, and study design, she has held key leadership positions in both clinical development and R&D, such as VP Clinical Development and Regulatory Affairs at Karo Bio AB. Prior to her executive roles, Maria worked at AstraZeneca, where she coordinated various clinical programs and projects. Her experience spans across therapeutic areas including endocrinology, CNS, cardiovascular, respiratory, nutrition, and cancer. Maria holds an MSc in Molecular Biology from the University of Lund.

In addition to her role at EpiEndo she has board-level experience at both private and listed companies, Maria is also a non-executive director at Paxman AB and Neuronano AB.

About ACCESS CHINA Partnering Forum

ACCESS CHINA Partnering Forum – Autumn Virtual Showcase is scheduled to be held on September 24th to 25th, and 27th, 2024, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, audience can have access to innovative pharma and healthcare products from worldwide.

Conference Name: ACCESS CHINA Partnering Forum

Date & Time: Sep 24 – 25 (live), and 27 (VoD) 2024, China time

Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception

Scale: Expected 500+ participants Online; 100 company roadshows

Participants: Pharma/Biotech senior management and BDs

View more information at https://biotochina.org/


REGISTER

To Register for ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum

For more information, please contact:

Wendi Xiang

Wxiang@yafocapital.com